Iftach Seri
Chief Executive Officer at Wavelength Pharmaceuticals Ltd.
Profile
Iftach Seri is currently the Chief Executive Officer & Director at Wavelength Pharmaceuticals Ltd.
and the Director at Remedix Care Ltd.
Iftach Seri active positions
| Companies | Position | Start |
|---|---|---|
Wavelength Pharmaceuticals Ltd.
 Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel. | Chief Executive Officer | 2017-11-28 |
Remedix Care Ltd.
 Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Part of Super-Pharm (Israel) Ltd., Remedix Care Ltd. is an Israeli company that manufactures drugs for hospitals. The company is based in Ashdod, Israel. The company was founded in 2018. The CEO is Shay Shabat. Remedix Care was acquired by Super-Pharm (Israel) Ltd. from Teva Pharmaceutical Industries Ltd. on April 23, 2021. | Director/Board Member | 2019-08-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Wavelength Pharmaceuticals Ltd.
Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel. | Health Technology |
Remedix Care Ltd.
Remedix Care Ltd. Pharmaceuticals: MajorHealth Technology Part of Super-Pharm (Israel) Ltd., Remedix Care Ltd. is an Israeli company that manufactures drugs for hospitals. The company is based in Ashdod, Israel. The company was founded in 2018. The CEO is Shay Shabat. Remedix Care was acquired by Super-Pharm (Israel) Ltd. from Teva Pharmaceutical Industries Ltd. on April 23, 2021. | Health Technology |
- Stock Market
- Insiders
- Iftach Seri
